This platform is currently totally free and created by doctors. 🩺

Specialties Drug Index Guidelines Classifications Pricing

Menu

Specialties Drug Index Guidelines Classifications Pricing

RxIndia

Loading clinical data...

The most trusted clinical drug reference for Indian healthcare professionals. Providing evidence-based monographs, dosage protocols, and expert guidelines to empower better clinical decisions.

Resources

Full Drug Index
Clinical Guidelines
Classifications
Specialties

Weekly Updates

Stay updated with the latest FDA approvals, drug alerts, and clinical practices.

Verified Clinical Information

"This platform is a clinical reference tool for educational purposes only. It is not a substitute for professional medical judgment, diagnosis, or treatment. Always seek the advice of a qualified physician."

© 2026 DrugsAtlas.

A Medical Intelligence Initiative

About Contact Privacy Terms

Developeredonesolutions

Home Therapeutic Index Endocrinology / Hepatology Antidiabetic / AntilipidemicDual PPAR α/γ Agonist (Glitazar class)

Dual PPAR α/γ Agonist (Glitazar class)

Medication Registry

Saroglitazar

Explore More

Browse all therapy groups under the Antidiabetic / Antilipidemic directory

View All Drugs Antidiabetic / Antilipidemic Home

Quick Links

Ask AI about Dual PPAR α/γ Agonist (Glitazar class)Global Drug Index